Opportunity ID: 334197

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-22-017
Funding Opportunity Title: Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 16, 2021
Last Updated Date: Jun 16, 2021
Original Closing Date for Applications: Oct 28, 2021
Current Closing Date for Applications: Oct 28, 2021
Archive Date: Dec 03, 2021
Estimated Total Program Funding: $8,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
City or township governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) aims to explore the role of adaptive immunity in Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). Specifically, the FOA seeks an understanding of brain immune surveillance, the generation of CNS-directed immune responses in neurodegenerative disorders, and the functional role of adaptive immunity in AD/ADRD onset and progression.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-017.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00267781 Sep 28, 2021 Jan 24, 2022 View

Package 1

Mandatory forms

334197 RR_SF424_2_0-2.0.pdf

334197 PHS398_CoverPageSupplement_5_0-5.0.pdf

334197 RR_OtherProjectInfo_1_4-1.4.pdf

334197 PerformanceSite_2_0-2.0.pdf

334197 RR_KeyPersonExpanded_2_0-2.0.pdf

334197 PHS398_ResearchPlan_4_0-4.0.pdf

334197 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

334197 RR_Budget_1_4-1.4.pdf

334197 RR_SubawardBudget30_1_4-1.4.pdf

334197 PHS398_ModularBudget_1_2-1.2.pdf

334197 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T11:53:09-05:00

Share This Post, Choose Your Platform!

About the Author: